Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000325

Drug Information
NameCinnarizine    
SynonymsCero-Aterin; Prestwick_115; Cinazyn; MLS001148649; Prestwick3_000278; Siptazin; Processine; NCGC00021488-05; CHEMBL43064; NCGC00018187-07; Spaderizine; AC1LU5GC; Cinnageron; Zepamol; DB00568; Glanil; cinnarizine; CID1547484; 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine; Katoseran; Cinarizine; Cinnarizine (JAN/USAN/INN); Lazeta; HMS1568H18; NCGC00018187-04; Denapol; 1-Cinnamyl-4-(diphenylmethyl)piperazine; Bio-0747; nchembio790-comp28; 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine; Eglen; Corathiem; Aplexal; Labyrin; 1-trans-Cinnamyl-4-diphenylmethylpiperazine; Hilactan; NCGC00021488-03; Cinnacet; Senoger; STK216257; Cerebolan; Aplactan; QTL1_000023; Carecin; Sepan; Artate; N-Benzhydryl-N'-cinnamylpiperazine; 7002-58-6 (di-hydrochloride); Lopac0_000314; Olamin; Dimitronal; Cinnarizinum [INN-Latin]; BSPBio_000156; 1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine; Cinarizina [INN-Spanish]; Prestwick2_000278; Stutgeron; R 1575; Cinnarizine [USAN:INN:BAN:JAN]; MolPort-002-056-760; 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine; Sedatromin; Midronal; Ixertol; Cinnarizinum; C5270_SIGMA; BRN 0626121; Libotasin; MLS002207295; UNII-3DI2E1X18L; EU-0100314; R-516; SMR000058307; LS-111394; Marisan; CHEBI:31403; BPBio1_000172; C 5270; D01295; R 516; Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-; Cinaperazine; Toliman; NCGC00021488-04; L001227; 1-Benzhydryl-4-cinnamylpiperazin; 298-57-7; 516 MD; MLS002222167; Dimitron; C26H28N2; Votegol; EINECS 206-064-8; BRD-K07220430-001-03-6; Mitronal; Piperazine, 1-cinnamyl-4-(diphenylmethyl)-; Folcodal; AKOS002134299; MLS000028498; Giganten; Cinnarizine Stugeron; Stugeron; MD 516; I01-3582; Cinarizina; Stutgin; Apotomin    
Trade NameStugeron; Stunarone    
CompanyJanssen Pharmaceutica    
IndicationVertigo/meniere's diseaseApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Allergic Agents    
CAS NumberCAS 298-57-7
FormularC26H28N2    
PubChem Compound IDCID 1547484.    
PubChem Substance IDSID 152478.    
ChEBI31403;    
SuperDrug ATC IDN07CA02;    
SuperDrug CAS ID000298577;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1Drug information of Cinnarizine, 2008 To Reference
Ref 2Central effects of cinnarizine: restricted use in aircrew. Aviat Space Environ Med. 2002 Jun;73(6):570-4. To Reference
Ref 3Effects of calcium-antagonistic drugs on the stimulation by carbamoylcholine and histamine of phosphatidylinositol turnover in longitudinal smooth muscle of guinea-pig ileum. Biochem J. 1976 Nov 15;160(2):163-9. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543